The global Veterinary Infusion Pumps Market continues to show strong momentum as the industry shifts toward advanced and reliable drug delivery technologies for animals. The market was valued at USD 325.1 million in 2023 and is expected to reach USD 623.8 million by 2032, growing at a CAGR of 7.52% from 2024 to 2032. Increasing investments in veterinary infrastructure, higher awareness of pet wellness, and the rising prevalence of chronic diseases in companion animals are key contributors shaping this upward trajectory.
Veterinary clinics, hospitals, and specialty care centers are adopting modern infusion systems to ensure accurate, consistent, and safe medication delivery. Conditions such as diabetes, renal disorders, and severe infections require precise dosing, strengthening the shift toward sophisticated infusion solutions across high-volume and small-volume clinical settings. As veterinary care becomes more aligned with human healthcare standards, demand for enhanced monitoring and fluid management continues to increase.
Moreover, the rising global trend of pet humanization plays a central role in market growth. Pet owners are more willing than ever to invest in advanced medical care, including surgical interventions, long-term therapy, and emergency treatment requiring continuous infusion support. Expanding access to pet insurance and government programs promoting improved animal welfare are also influencing market adoption.
Get free Sample Report@ https://www.snsinsider.com/sample-request/6089
Companion animals remain the leading segment, accounting for a significant majority of total market share. Growing pet ownership, particularly in Europe, North America, China, and India, is expected to drive sustained demand for infusion technologies tailored for dogs, cats, and small mammals. With chronic illness rates rising in pets, infusion pumps that support continuous treatments have become essential across modern veterinary facilities. The strong emotional bond between pet owners and their animals further accelerates the adoption of quality healthcare devices.
On the product front, volumetric infusion pumps dominated the market in 2023, representing more than three fourths of global revenue. Their high adoption rate is credited to widespread use in fluid therapy, blood transfusion support, and nutrient administration. Technological upgrades, such as wireless connectivity for real-time monitoring, enhanced battery performance, and intuitive digital interfaces, continue to elevate clinical value. As veterinary centers increasingly embrace connected health solutions, volumetric systems remain the preferred choice for both routine and critical care.
Syringe infusion pumps also maintain a promising growth curve, particularly for low-volume dosing requirements. These pumps are valued in specialized treatments, anesthesia delivery, and procedures requiring accurate micro-infusion control. Their versatility and ease of use make them a reliable option for smaller clinics and mobile veterinary units. Increasing adoption of portable, lightweight pump designs is expected to support market expansion in regions with developing veterinary ecosystems.
By route of administration, the intravenous segment led the market with nearly 88% share in 2023. IV delivery continues to be the preferred method for rapid therapeutic response, making it indispensable in emergency and intensive care settings. The growing availability of user-friendly portable pumps is also increasing IV adoption for home-based veterinary care, especially for long-term treatments. Enhanced veterinarians’ training and improvements in veterinary hospital equipment standards are further strengthening IV usage.
Veterinary hospitals and clinics held the largest end-use share at 47% in 2023. Their increasing numbers worldwide, supported by government programs aimed at improving animal health services, is reinforcing the demand for advanced infusion technologies. Many hospitals are also forming partnerships with technology manufacturers to gain access to upgraded devices that offer greater efficiency, safety, and automated alert features. As veterinary practices expand their services to address growing caseloads, infusion pumps are becoming a critical part of treatment workflows.
Regionally, North America maintains leadership with a 32% share in 2023, supported by strong pet ownership rates and robust veterinary expenditure. Favorable pet insurance penetration and economic stability enable higher spending on premium veterinary devices. Europe also represents a prominent market, driven by strict veterinary care regulations and a substantial companion animal population. Asia Pacific, however, is expected to grow at the fastest pace through 2032. Rising disposable income, expanding awareness of animal health, and increased investment from domestic technology providers are accelerating demand for modern infusion systems across the region.
Leading players in the market continue to introduce new pump models, integrate digital control systems, and expand their global distribution networks. Companies such as B. Braun Melsungen, Mindray, Heska Corporation, Burtons Medical Equipment, and ICU Medical are among those shaping the competitive landscape with continuous product innovation. Government agencies have also emphasized the importance of accurate drug delivery for managing animal disease outbreaks and improving treatment outcomes, further boosting the adoption of infusion pump technologies.
Other Trending Reports
Lung Cancer Surgery Market Growth
Medical Electrodes Market Growth
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Rohan Jadhav – Principal Consultant
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email: [email protected]
